Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

A Digital Support to Facilitate Sustainable Return to Work for Persons With Chronic Pain and Their Employers (SWEPPE)

9 mars 2022 uppdaterad av: Mathilda Björk, Linkoeping University

An Evidence-based Digital Support for One Year to Facilitate a Sustainable Return to Work for Persons With Chronic Musculoskeletal Pain and Their Employers: Study Protocol for a Registry-based Multicentre Randomized Controlled Trial.

Chronic musculoskeletal pain (CMSP) severely affects the individual's quality of life, functioning and ability to work, and comes with significant societal costs for sick leave and loss of productivity. After completing an Interdisciplinary Pain Rehabilitation Program (IPRP), patients with CMSP experience a gap in the return to work (RTW) process when the responsibility for RTW is taken over by the employer. To fill this gap, we aim to evaluate the clinical effectiveness of a digital support (SWEPPE) for promoting a sustainable RTW for persons with CMSP and to facilitate the employers' supportive role and responsibilities in the process. Our hypothesis is that using SWEPPE will decrease the need for sick-leave.

SWEPPE is a smartphone application where the individual can create an action plan, perform daily registrations of health aspects, self-monitoring of health aspects and goals, have access to a library with evidence-based facts and a coach, and the possibility to share information with the employer.The employer access SWEPPE via a web application.

In this trial, we will recruit patients with CMSP aged 18-65 years who have completed IPRP, and who need support during RTW or continued support at the work placement for creating a sustainable work situation. The participants will be randomly assigned to either receive SWEPPE or to the control group. The intervention group will use SWEPPE during twelve months and the control group will not receive any active intervention for RTW which is standard clinical practice. Participants will be recruited from specialist and primary care level units connected to the Swedish National Quality Registry for Pain Rehabilitation (SQRP) and providing IPRP for patients with CMSP.

All participants will fill in questionnaires when they have completed the rehabilitation program and before the intervention starts. Study ending assessment will be performed after twelve months.

The clinical effectiveness of SWEPPE will be assessed by number of days with sickness cash benefit. Several dimensions of sick-leave will be assessed according to the Swedish Social Insurance Agency's (SSIA) proposal of outcome measures of RTW. Other outcomes and explanatory variables including important domains affected by CMSP such as health-related quality of life, functioning and work ability will be collected. A sample size calculation indicates the need for recruiting 360 participants (n=180 for each group).

Studieöversikt

Status

Rekrytering

Betingelser

Intervention / Behandling

Studietyp

Interventionell

Inskrivning (Förväntat)

360

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studieorter

      • Danderyd, Sverige, 182 57
        • Rekrytering
        • Danderyd Hospital
      • Karlstad, Sverige
        • Har inte rekryterat ännu
        • Smärtcentrum
      • Linköping, Sverige, 581 83
        • Rekrytering
        • County council of Ostergotland
      • Lund, Sverige
        • Har inte rekryterat ännu
        • Smärtcentrum
      • Stockholm, Sverige
        • Har inte rekryterat ännu
        • Spine Center

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 65 år (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

Patients entering the trial must have completed IPRP. The principal inclusion criteria for IPRP in Sweden are:

  • persistent or intermittent pain lasting ≥3 months
  • pain affecting daily activities to a large extent,
  • completed systematic assessment and non-pharmacological optimization is completed,
  • screening for psychosocial risk factors and differential diagnosis completed

In addition the following criteria will be applied:

  • Completed participation in an Interdisciplinary Pain Rehabilitation Program (IPRP) at any of the participating units.
  • Having an employment to return to after IPRP or having returned to work but need continued support for creating a sustainable work situation after IPRP.

Exclusion criteria:

  • Completed IPRP but are unemployed or unable to return to work.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: SWEPPE
Participants will receive the smartphone application SWEPPE.
In the smartphone application SWEPPE the individual can create an action plan, perform daily registrations of health aspects, self-monitoring of health aspects and goals, have access to a library with evidence-based facts and a coach, and possibility to share information with the employer.
Inget ingripande: Control
Participants randomized to the control group will not receive any active intervention for return to work after completing an Interdisciplinary Pain Rehabilitation Program .

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Sick leave
Tidsram: 12 months follow up after IPRP
Number of gross and net days with sickness cash benefit
12 months follow up after IPRP

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Return to work
Tidsram: 12 months follow up after IPRP
Return to work (partially or full time) every month
12 months follow up after IPRP
Sick-leave spells per months
Tidsram: 12 months follow up after IPRP
Number of sick-leave spells (per month)
12 months follow up after IPRP
Return to work group level
Tidsram: 12 months follow up after IPRP
Proportions of a group who returns to full- or part-time work (per month)
12 months follow up after IPRP
Working days before new sick leave
Tidsram: 12 months follow up after IPRP
Number of days in work before new sick leave during study period
12 months follow up after IPRP
Proportion back to work
Tidsram: 12 months follow up after IPRP
Proportion of a group back to work >28 days (full- or part time) before a new sick-leave spell occurs
12 months follow up after IPRP
Total sick-leave spells
Tidsram: 12 months follow up after IPRP
Number of sick-leave spells during study period
12 months follow up after IPRP
Length of total sick leave
Tidsram: 12 months follow up after IPRP
Length of total sick leave during study period
12 months follow up after IPRP
Pain intensity last 7 days
Tidsram: Baseline and 12 months
Numeric rating scale
Baseline and 12 months
Consequences of pain on daily life
Tidsram: Baseline and 12 months
Multidimensional Pain Inventory Swedish version
Baseline and 12 months
Overall emotional distress
Tidsram: Baseline and 12 months
Hospital Anxiety and Depression Scale Swedish version
Baseline and 12 months
Physical and mental health
Tidsram: Baseline and 12 months
RAND-36 Swedish version
Baseline and 12 months
Goal fulfilment and satisfaction during the study period
Tidsram: Baseline and 12 months
Self-reported data
Baseline and 12 months
Self-reported physical work environment
Tidsram: Baseline and 12 months
Questionnaire based on the Swedish Work Environment Authority ergonomics checklist
Baseline and 12 months

Andra resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Self-reported fatigue the last 7 days
Tidsram: Baseline and 12 months
Numeric rating scale
Baseline and 12 months
Self-reported level of sleepiness
Tidsram: Baseline and 12 months
Karolinska Sleepiness Scale Swedish version
Baseline and 12 months
Self-reported level of sleep disturbance
Tidsram: Baseline and 12 months
Insomnia Severity Index Swedish version
Baseline and 12 months
Self-reported fear of movement
Tidsram: Baseline and 12 months
Tampa Scale for Kinesiophobia Swedish version
Baseline and 12 months
Self-reported physical activity
Tidsram: Baseline and 12 months
the National Board of Health and Welfare's three questions on physical activity, exercise, and sedentary behavior.
Baseline and 12 months
Pain catastrophizing
Tidsram: Baseline and 12 months
Pain Catastrophizing scale Swedish version
Baseline and 12 months
Perceived work ability
Tidsram: Baseline and 12 months
Work Ability Index Swedish version
Baseline and 12 months
Self-reported demands, control, and support at the workplace
Tidsram: Baseline and 12 months
Demand Control Support Questionnaire Swedish version
Baseline and 12 months
Perceived life Satisfaction
Tidsram: Baseline and 12 months
Life satisfaction Scale Swedish version
Baseline and 12 months
Self-reported work situation during the study period
Tidsram: Baseline and 12 months
Barriers for return to work, strategies to handle barriers and need of support from the employer
Baseline and 12 months
Self-reported workload an average day
Tidsram: Baseline and 12 months
Number of hours per day for paid work and unpaid household work
Baseline and 12 months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Mathilda Björk, PhD, Linkoeping University

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Allmänna publikationer

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

1 mars 2022

Primärt slutförande (Förväntat)

1 december 2023

Avslutad studie (Förväntat)

1 december 2024

Studieregistreringsdatum

Först inskickad

24 september 2021

Först inskickad som uppfyllde QC-kriterierna

24 september 2021

Första postat (Faktisk)

27 september 2021

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

25 mars 2022

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

9 mars 2022

Senast verifierad

1 mars 2022

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Kliniska prövningar på Kronisk smärta

3
Prenumerera